Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

[The small blue pills]

Christian M Jespersen

Ugeskrift for Laeger

|October 5, 2002

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial.

American heart journal·2014

Same author

Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations.

The Annals of thoracic surgery·2014

Same author

Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial.

The Journal of thoracic and cardiovascular surgery·2013

Same author

Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease.

Journal of clinical epidemiology·2012

Same author

Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?

Cardiology·2011

Same author

High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.

Scandinavian journal of clinical and laboratory investigation·2010

Related Experiment Videos

[The small blue pills]

Related Concept Videos

Related Articles

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial.

Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations.

Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial.

Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease.

Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?

High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.